Clinical Trial: The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
Brief Summary: To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
Detailed Summary:
Sponsor: Eisai Inc.
Current Primary Outcome: Assessment of cognitive and global function in subjects with MCI.
Original Primary Outcome: Same as current
Current Secondary Outcome: Behavioral, global and cognitive outcomes; Neuroimaging
Original Secondary Outcome: Same as current
Information By: Eisai Inc.
Dates:
Date Received: February 16, 2006
Date Started: December 2003
Date Completion:
Last Updated: March 31, 2011
Last Verified: March 2011